Wells Fargo’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Wells Fargo’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-153,804	Closed	-$10.5M	–	7584
2022 Q3	$10.5M	Sell	153,804 -111,562	-42%	-$7.6M	﹤0.01%	1433
2022 Q2	$8.48M	Sell	265,366 -23,718	-8%	-$758K	﹤0.01%	1607
2022 Q1	$10M	Buy	289,084 +128,489	+80%	+$4.45M	﹤0.01%	1751
2021 Q4	$4.7M	Buy	160,595 +51,601	+47%	+$1.51M	﹤0.01%	2488
2021 Q3	$2.78M	Buy	108,994 +42,165	+63%	+$1.07M	﹤0.01%	3227
2021 Q2	$2.34M	Sell	66,829 -16,940	-20%	-$593K	﹤0.01%	3380
2021 Q1	$3.41M	Sell	83,769 -82,065	-49%	-$3.34M	﹤0.01%	3050
2020 Q4	$7.18M	Buy	165,834 +27,841	+20%	+$1.21M	﹤0.01%	2373
2020 Q3	$7.61M	Buy	137,993 +5,161	+4%	+$285K	﹤0.01%	2095
2020 Q2	$8.39M	Buy	132,832 +24,684	+23%	+$1.56M	﹤0.01%	1984
2020 Q1	$5.53M	Sell	108,148 -48,540	-31%	-$2.48M	﹤0.01%	2126
2019 Q4	$12.5M	Sell	156,688 -19,693	-11%	-$1.57M	﹤0.01%	1798
2019 Q3	$8.56M	Buy	176,381 +9,037	+5%	+$439K	﹤0.01%	2051
2019 Q2	$8.8M	Buy	167,344 +28,203	+20%	+$1.48M	﹤0.01%	2058
2019 Q1	$7.37M	Buy	139,141 +22,525	+19%	+$1.19M	﹤0.01%	2173
2018 Q4	$4.79M	Buy	116,616 +9,462	+9%	+$388K	﹤0.01%	2451
2018 Q3	$4.07M	Sell	107,154 -3,530	-3%	-$134K	﹤0.01%	2790
2018 Q2	$5M	Buy	110,684 +8,570	+8%	+$387K	﹤0.01%	2663
2018 Q1	$4.93M	Sell	102,114 -7	-0%	-$338	﹤0.01%	2603
2017 Q4	$4.02M	Sell	102,121 -1,729	-2%	-$68K	﹤0.01%	2757
2017 Q3	$3.22M	Sell	103,850 -38,240	-27%	-$1.19M	﹤0.01%	2862
2017 Q2	$3.89M	Buy	142,090 +21,522	+18%	+$589K	﹤0.01%	2617
2017 Q1	$4.44M	Buy	120,568 +24,363	+25%	+$898K	﹤0.01%	2505
2016 Q4	$1.39M	Buy	96,205 +75,461	+364%	+$1.09M	﹤0.01%	3392
2016 Q3	$478K	Buy	20,744 +7,212	+53%	+$166K	﹤0.01%	3865
2016 Q2	$225K	Buy	13,532 +9,570	+242%	+$159K	﹤0.01%	4205
2016 Q1	$63K	Sell	3,962 -45	-1%	-$716	﹤0.01%	4938
2015 Q4	$129K	Buy	4,007 +3,979	+14,211%	+$128K	﹤0.01%	4574
2015 Q3	$1K	Buy	+28	New	+$1K	﹤0.01%	5789